METTL25B
gene geneOn this page
Also known as CGI-41
Summary
METTL25B (methyltransferase like 25B, HGNC:24273) is a protein-coding gene on chromosome 1q23.1, encoding Methyltransferase-like protein 25B (Q96FB5).
Predicted to enable rRNA (adenine-N6,N6-)-dimethyltransferase activity. Predicted to be involved in rRNA methylation. Predicted to be located in membrane.
Source: NCBI Gene 51093 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 99 total
- MANE Select transcript:
NM_015997
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24273 |
| Approved symbol | METTL25B |
| Name | methyltransferase like 25B |
| Location | 1q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-41 |
| Ensembl gene | ENSG00000143303 |
| Ensembl biotype | protein_coding |
| Entrez | 51093 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 16 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000368216, ENST00000368218, ENST00000462397, ENST00000476229, ENST00000481920, ENST00000484742, ENST00000497515, ENST00000517871, ENST00000519086, ENST00000522237, ENST00000524343, ENST00000892483, ENST00000892484, ENST00000892485, ENST00000892486, ENST00000917458, ENST00000917459, ENST00000917460, ENST00000917461, ENST00000917462
RefSeq mRNA: 2 — MANE Select: NM_015997
NM_001142560, NM_015997
CCDS: CCDS1154, CCDS44246
Canonical transcript exons
ENST00000368216 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000959151 | 156734009 | 156734493 |
| ENSE00001167979 | 156733377 | 156733520 |
| ENSE00001196007 | 156731991 | 156732115 |
| ENSE00001446593 | 156728469 | 156729215 |
| ENSE00003537533 | 156736632 | 156736960 |
| ENSE00003657575 | 156732281 | 156732473 |
| ENSE00003675907 | 156735725 | 156735909 |
| ENSE00003678647 | 156732985 | 156733047 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 96.80.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.8055 / max 142.4192, expressed in 1807 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5762 | 6.6911 | 1758 |
| 5763 | 5.6592 | 1712 |
| 5765 | 3.1641 | 1340 |
| 5764 | 2.0164 | 1228 |
| 5766 | 0.2390 | 94 |
| 5767 | 0.0357 | 5 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.14 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.72 | gold quality |
| right testis | UBERON:0004534 | 95.29 | gold quality |
| right ovary | UBERON:0002118 | 95.16 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.13 | gold quality |
| left ovary | UBERON:0002119 | 95.11 | gold quality |
| body of pancreas | UBERON:0001150 | 95.07 | gold quality |
| left testis | UBERON:0004533 | 94.86 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 94.74 | gold quality |
| thyroid gland | UBERON:0002046 | 94.65 | gold quality |
| endocervix | UBERON:0000458 | 94.62 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.52 | gold quality |
| left uterine tube | UBERON:0001303 | 94.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.34 | gold quality |
| ectocervix | UBERON:0012249 | 94.27 | gold quality |
| body of uterus | UBERON:0009853 | 94.25 | gold quality |
| body of stomach | UBERON:0001161 | 94.24 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.18 | gold quality |
| skin of abdomen | UBERON:0001416 | 93.92 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.87 | gold quality |
| granulocyte | CL:0000094 | 93.81 | gold quality |
| transverse colon | UBERON:0001157 | 93.72 | gold quality |
| metanephros cortex | UBERON:0010533 | 93.70 | gold quality |
| skin of leg | UBERON:0001511 | 93.69 | gold quality |
| tibial nerve | UBERON:0001323 | 93.46 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.17 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.11 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.04 | gold quality |
| pituitary gland | UBERON:0000007 | 92.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.99 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting METTL25B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
| HSA-MIR-4738-3P | 98.98 | 67.98 | 1846 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-6894-5P | 98.70 | 63.78 | 809 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-6764-3P | 98.44 | 67.64 | 1153 |
| HSA-MIR-6824-3P | 98.44 | 67.62 | 1154 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-326 | 98.25 | 66.44 | 1565 |
| HSA-MIR-1245B-3P | 98.01 | 68.91 | 1387 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-612 | 97.26 | 65.95 | 1597 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
| HSA-MIR-6839-5P | 96.74 | 68.29 | 1088 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mettl25b | ENSDARG00000089033 |
| mus_musculus | Mettl25b | ENSMUSG00000004896 |
| rattus_norvegicus | Mettl25b | ENSRNOG00000011645 |
| drosophila_melanogaster | CG2906 | FBGN0033240 |
| caenorhabditis_elegans | F25H2.12 | WBGENE00009123 |
Paralogs (1): METTL25 (ENSG00000127720)
Protein
Protein identifiers
Methyltransferase-like protein 25B — Q96FB5 (reviewed: Q96FB5)
Alternative names: Protein RRNAD1, Ribosomal RNA adenine dimethylase domain-containing protein 1
All UniProt accessions (6): Q96FB5, E5RHI7, E5RI42, E5RIL6, E5RJL6, H0YBL9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the METTL25 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96FB5-1 | 1 | yes |
| Q96FB5-2 | 2 |
RefSeq proteins (2): NP_001136032, NP_057081* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020596 | rRNA_Ade_Mease_Trfase_CS | Conserved_site |
| IPR025714 | Methyltranfer_dom | Domain |
| IPR029063 | SAM-dependent_MTases_sf | Homologous_superfamily |
| IPR052220 | METTL25 | Family |
Pfam: PF13679
UniProt features (7 total): splice variant 2, chain 1, transmembrane region 1, coiled-coil region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96FB5-F1 | 91.39 | 0.74 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 94 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOBP_RNA_METHYLATION, GOBP_RNA_MODIFICATION, EGR1_01, HAN_SATB1_TARGETS_DN, ACEVEDO_LIVER_CANCER_UP, GOBP_RRNA_MODIFICATION, GOBP_METHYLATION, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RRNA_METHYLATION, AIYAR_COBRA1_TARGETS_UP, STAT1_02, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, MGGAAGTG_GABP_B, GOMF_RNA_METHYLTRANSFERASE_ACTIVITY
GO Biological Process (2): rRNA modification (GO:0000154), rRNA methylation (GO:0031167)
GO Molecular Function (1): rRNA (adenine-N6,N6-)-dimethyltransferase activity (GO:0000179)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| rRNA processing | 1 |
| RNA modification | 1 |
| rRNA modification | 1 |
| RNA methylation | 1 |
| N-methyltransferase activity | 1 |
| rRNA (adenine) methyltransferase activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
364 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| METTL25B | METTL9 | Q9H1A3 | 530 |
| METTL25B | CSKMT | A8MUP2 | 490 |
| METTL25B | METTL13 | Q8N6R0 | 485 |
| METTL25B | NTMT2 | Q5VVY1 | 484 |
| METTL25B | METTL26 | Q96S19 | 477 |
| METTL25B | EEF1AKMT3 | Q96AZ1 | 474 |
| METTL25B | KRABD3 | A5PL33 | 463 |
| METTL25B | METTL27 | Q8N6F8 | 459 |
| METTL25B | METTL17 | Q9H7H0 | 447 |
| METTL25B | RSAD1 | Q9HA92 | 444 |
| METTL25B | EEF1AKMT2 | Q5JPI9 | 427 |
| METTL25B | HEATR4 | Q86WZ0 | 419 |
| METTL25B | TRMT44 | Q8IYL2 | 418 |
| METTL25B | METTL18 | O95568 | 413 |
| METTL25B | NRBP2 | Q9NSY0 | 413 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ERF | TBL1X | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (4): RRNAD1 (Affinity Capture-MS), RRNAD1 (Affinity Capture-MS), RRNAD1 (Affinity Capture-MS), RRNAD1 (Affinity Capture-RNA)
ESM2 similar proteins: A2AA28, A4FV42, A4FV98, A6NDG6, D3YWP0, D3ZVU9, O15315, O35719, O70277, O75382, O94759, P21964, P57775, P81799, Q2TBS1, Q3UGX3, Q4R3I0, Q5E9V4, Q5H879, Q5RJL2, Q5SUV1, Q6DC64, Q7Z624, Q86WI3, Q86XA0, Q8BNV1, Q8C436, Q8CIW5, Q8IZ69, Q8N8L6, Q8N9F0, Q8VCX6, Q8WXB1, Q96AZ1, Q96FB5, Q96RR1, Q9BQD7, Q9BRQ3, Q9BUU2, Q9CQL0
Diamond homologs: Q5E9V4, Q6AYG0, Q8BZG5, Q96FB5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1582 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:156733366:C:A | acceptor_gain | 1.0000 |
| 1:156733368:T:TA | acceptor_gain | 1.0000 |
| 1:156733371:CTCCA:C | acceptor_loss | 1.0000 |
| 1:156733372:TCCAG:T | acceptor_loss | 1.0000 |
| 1:156733373:CCA:C | acceptor_loss | 1.0000 |
| 1:156733374:CA:C | acceptor_loss | 1.0000 |
| 1:156733375:A:AG | acceptor_gain | 1.0000 |
| 1:156733375:AG:A | acceptor_gain | 1.0000 |
| 1:156733376:G:GG | acceptor_gain | 1.0000 |
| 1:156733376:GG:G | acceptor_gain | 1.0000 |
| 1:156733376:GGGCC:G | acceptor_gain | 1.0000 |
| 1:156733396:T:TA | acceptor_gain | 1.0000 |
| 1:156733516:CGCAG:C | donor_loss | 1.0000 |
| 1:156733517:GCAGG:G | donor_loss | 1.0000 |
| 1:156733518:CAGGT:C | donor_loss | 1.0000 |
| 1:156733522:T:G | donor_loss | 1.0000 |
| 1:156735903:G:GT | donor_gain | 1.0000 |
| 1:156735908:GG:G | donor_gain | 1.0000 |
| 1:156735909:GG:G | donor_gain | 1.0000 |
| 1:156729216:G:GG | donor_gain | 0.9900 |
| 1:156729227:GGGGC:G | donor_gain | 0.9900 |
| 1:156729228:GGGCG:G | donor_gain | 0.9900 |
| 1:156729229:G:T | donor_gain | 0.9900 |
| 1:156732039:G:GT | donor_gain | 0.9900 |
| 1:156732983:A:AG | acceptor_gain | 0.9900 |
| 1:156732983:AGTT:A | acceptor_gain | 0.9900 |
| 1:156732984:G:GG | acceptor_gain | 0.9900 |
| 1:156732984:GTT:G | acceptor_gain | 0.9900 |
| 1:156732984:GTTG:G | acceptor_gain | 0.9900 |
| 1:156733376:GGGC:G | acceptor_gain | 0.9900 |
AlphaMissense
3014 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:156736680:G:T | R452I | 0.998 |
| 1:156732446:G:C | K134N | 0.997 |
| 1:156732446:G:T | K134N | 0.997 |
| 1:156732455:G:C | E137D | 0.997 |
| 1:156732455:G:T | E137D | 0.997 |
| 1:156736680:G:C | R452T | 0.997 |
| 1:156732433:T:A | V130D | 0.996 |
| 1:156734144:C:G | H258D | 0.996 |
| 1:156736658:T:C | F445L | 0.996 |
| 1:156736660:C:A | F445L | 0.996 |
| 1:156736660:C:G | F445L | 0.996 |
| 1:156732454:A:T | E137V | 0.995 |
| 1:156735865:A:T | E421V | 0.995 |
| 1:156736681:A:C | R452S | 0.995 |
| 1:156736681:A:T | R452S | 0.995 |
| 1:156733425:A:C | S181R | 0.994 |
| 1:156733427:C:A | S181R | 0.994 |
| 1:156733427:C:G | S181R | 0.994 |
| 1:156732443:G:C | K133N | 0.993 |
| 1:156732443:G:T | K133N | 0.993 |
| 1:156732444:A:G | K134E | 0.993 |
| 1:156734225:T:C | C285R | 0.993 |
| 1:156735883:A:T | D427V | 0.993 |
| 1:156734146:C:A | H258Q | 0.992 |
| 1:156734146:C:G | H258Q | 0.992 |
| 1:156734154:G:T | G261V | 0.992 |
| 1:156735886:G:C | R428P | 0.992 |
| 1:156731994:T:C | F39L | 0.991 |
| 1:156731996:T:A | F39L | 0.991 |
| 1:156731996:T:G | F39L | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000265049 (1:156735212 C>A,G), RS1000402548 (1:156731851 G>T), RS1000456130 (1:156731518 G>T), RS1000639299 (1:156734891 T>C), RS1001183087 (1:156729224 A>G), RS1001387632 (1:156733342 G>A,T), RS1001439893 (1:156732964 C>A,T), RS1001537087 (1:156729292 G>A,T), RS1001609278 (1:156729531 T>C), RS1002386765 (1:156728244 C>A,T), RS1002391850 (1:156734754 A>G,T), RS1002747236 (1:156728529 C>A,T), RS1003220980 (1:156730539 C>T), RS1003293153 (1:156730815 C>T), RS1003801619 (1:156729405 CTTTT>C,CTT,CTTT,CTTTTT,CTTTTTT,CTTTTTTTTTTT)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_368 | Refractive error | 7.000000e-38 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TJ79 | HAP1 RRNAD1 (-) 1 | Cancer cell line | Male |
| CVCL_XS30 | HAP1 RRNAD1 (-) 2 | Cancer cell line | Male |
| CVCL_XS31 | HAP1 RRNAD1 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.